Correction: The anti-rheumatic drug, leflunomide, synergizes with MEK inhibition to suppress melanoma growth.

Hanson, Kimberley; Robinson, Stephen D; Al-Yousuf, Karamallah; Hendry, Adam E; Sexton, Darren W; Sherwood, Victoria; Wheeler, Grant N

Hanson, Kimberley; Robinson, Stephen D; Al-Yousuf, Karamallah; Hendry, Adam E; Sexton, Darren W; Sherwood, Victoria; Wheeler, Grant N.

Afiliação

Hanson K; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Robinson SD; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Al-Yousuf K; School of Pharmacy, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Hendry AE; Present address: Division of Cancer Sciences, School of Medicine, Ninewells Hospital and Medical School, University of Dundee, Dundee, DD1 9SY, UK.
Sexton DW; School of Biological Sciences, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Sherwood V; Norwich Medical School, University of East Anglia, Norwich Research Park, Norwich, NR4 7TJ, UK.
Wheeler GN; Present address: Pharmacy and Biomedical Sciences, Liverpool John Moores University, Liverpool, L3 3AF, UK.

Oncotarget ; 9(93): 36645, 2018 11 27.

Article em En | MEDLINE | ID: mdl-30564304

ABSTRACT

ABSTRACT

[This corrects the article DOI 10.18632/oncotarget.23378.].

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: Oncotarget Ano de publicação: 2018 Tipo de documento: Article País de afiliação: Reino Unido

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google